Clinical Trials Logo

Couples clinical trials

View clinical trials related to Couples.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03846505 Active, not recruiting - Clinical trials for Alcohol Use Disorder

Oxytocin to Enhance Alcohol Behavioral Couple Therapy (ABCT)

Start date: May 16, 2019
Phase: Phase 2
Study type: Interventional

Alcohol Behavioral Couples Therapy (ABCT) is a manualized 12-session, weekly psychosocial intervention that simultaneously reduces alcohol use disorder (AUD) severity and improves relationship functioning. However, there remains room to improve ABCT outcomes. A growing literature suggests that intranasal oxytocin is a medication that holds promise to achieve that goal. Oxytocin has demonstrated the ability to increase prosocial behavior (e.g., trust, safety, social cognition) and restore sensitivity to natural rewards such as interpersonal relationships that are commonly eroded in the context of addiction. Oxytocin has also demonstrated the ability to reduce substance use behaviors (e.g., craving, self-administration, tolerance, withdrawal), and improves the neurobiological foundations of AUD. The primary objective of this Stage II study is to test the efficacy of oxytocin versus placebo in improving (1) AUD symptom severity, (2) relationship functioning, and (3) corticolimbic connectivity among couples receiving ABCT therapy.